Literature DB >> 20494126

Advances in eicosanoid research, novel therapeutic implications.

Jesper Z Haeggström1, Agnes Rinaldo-Matthis, Craig E Wheelock, Anders Wetterholm.   

Abstract

Eicosanoids are a family of oxygenated metabolites of arachidonic acid, including the prostaglandins, thromboxanes, leukotrienes and lipoxins. These lipid mediators play essential roles in normal cellular homeostasis as well as in a number of disease states. This review will focus on recent advances in the field of eicosanoids and highlight specific discoveries and achievements. Emphasis will be placed on structure and receptor biology, which are of significant pharmacological and clinical relevance. 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20494126     DOI： 10.1016/j.bbrc.2010.03.140

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN： 0006-291X            Impact factor:   3.575


  40 in total

Review 1.  Chagas heart disease: report on recent developments.

Authors:  Fabiana S Machado; Linda A Jelicks; Louis V Kirchhoff; Jamshid Shirani; Fnu Nagajyothi; Shankar Mukherjee; Randin Nelson; Christina M Coyle; David C Spray; Antonio C Campos de Carvalho; Fangxia Guan; Cibele M Prado; Michael P Lisanti; Louis M Weiss; Susan P Montgomery; Herbert B Tanowitz
Journal:  Cardiol Rev       Date:  2012 Mar-Apr       Impact factor: 2.644

2.  Mir-351-5p contributes to the establishment of a pro-inflammatory environment in the H9c2 cell line by repressing PTEN expression.

Authors:  Walmir da Silva; Robson Augusto Souza dos Santos; Karen C M Moraes
Journal:  Mol Cell Biochem       Date:  2015-11-05       Impact factor: 3.396

Review 3.  Polyunsaturated fatty acid metabolism in prostate cancer.

Authors:  Isabelle M Berquin; Iris J Edwards; Steven J Kridel; Yong Q Chen
Journal:  Cancer Metastasis Rev       Date:  2011-12       Impact factor: 9.264

Review 4.  The vasculature in chagas disease.

Authors:  Cibele M Prado; Linda A Jelicks; Louis M Weiss; Stephen M Factor; Herbert B Tanowitz; Marcos A Rossi
Journal:  Adv Parasitol       Date:  2011       Impact factor: 3.870

Review 5.  Bioactive lipids in Trypanosoma cruzi infection.

Authors:  Fabiana S Machado; Shankar Mukherjee; Louis M Weiss; Herbert B Tanowitz; Anthony W Ashton
Journal:  Adv Parasitol       Date:  2011       Impact factor: 3.870

6.  Ubiquitin activates patatin-like phospholipases from multiple bacterial species.

Authors:  David M Anderson; Hiromi Sato; Aaron T Dirck; Jimmy B Feix; Dara W Frank
Journal:  J Bacteriol       Date:  2014-11-17       Impact factor: 3.490

7.  Systems biology analysis of the endocannabinoid system reveals a scale-free network with distinct roles for anandamide and 2-arachidonoylglycerol.

Authors:  Nicola Bernabò; Barbara Barboni; Mauro Maccarrone
Journal:  OMICS       Date:  2013-10-11

Review 8.  Impact of soluble epoxide hydrolase and epoxyeicosanoids on human health.

Authors:  Christophe Morisseau; Bruce D Hammock
Journal:  Annu Rev Pharmacol Toxicol       Date:  2012-09-27       Impact factor: 13.820

9.  Quantitative assays for esterified oxylipins generated by immune cells.

Authors:  Alwena H Morgan; Victoria J Hammond; Lloyd Morgan; Christopher P Thomas; Keri A Tallman; Yoel R Garcia-Diaz; Christopher McGuigan; Michaela Serpi; Ned A Porter; Robert C Murphy; Valerie B O'Donnell
Journal:  Nat Protoc       Date:  2010-11-10       Impact factor: 13.491

10.  Microarray analysis of the mammalian thromboxane receptor-Trypanosoma cruzi interaction.

Authors:  Herbert B Tanowitz; Aparna Mukhopadhyay; Anthony W Ashton; Michael P Lisanti; Fabiana S Machado; Louis M Weiss; Shankar Mukherjee
Journal:  Cell Cycle       Date:  2011-04-01       Impact factor: 4.534
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.